None listed
Conditions
Interventions
Intervention1: Test Product: TomaGlowTM: Test Product: TomaGlowTM Brightening Cream
Dose: 1gm twice a day after face wash. apply sunscreen half hour after the cream
Route of Administration: Topical, D
Sponsors
Fixderma India Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Gender Male and Female 30 Female and 6 males. 2.Subject having dull or dehydrated skin with pigmentation 3.Non-pregnant, non-lactating female. 4.Age between 18 to 50. 5.Subject willing to give written informed consent 6.Women of child bearing potential must have a negative urine pregnancy test 7.Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE. 8.Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
Exclusion criteria
Exclusion criteria: 1.Subjects who are pregnant, breast feeding, or planning to become pregnant during the study 2.Volunteers with skin conditions such as eczema, psoriasis, etc 3.Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition. 4.Have open sore or open lesions in the treatment area. 5.Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 6.Have participated in any interventional clinical trial in the previous 30 days. 7.Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents. 8.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids. 9.Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in Skin Gloss 2. Change in Hydration 3. Change in Skin Lightness 4. Change in Melanin Index 5. Change in Smoothness and Skin Even Tone 6. Change in Dark Spots 7. Change in TEWL Timepoint: At Day 0, Day 14, 28 Day | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed